Nilsine Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $608K | Buy |
8,704
+9
| +0.1% | +$629 | 0.06% | 240 |
|
|
2025
Q1 | $639K | Sell |
8,695
-342
| -4% | -$25.1K | 0.07% | 217 |
|
|
2024
Q4 | $592K | Sell |
9,037
-72
| -0.8% | -$4.72K | 0.06% | 228 |
|
|
2024
Q3 | $710K | Sell |
9,109
-140
| -2% | -$10.9K | 0.09% | 201 |
|
|
2024
Q2 | $721K | Buy |
9,249
+1,714
| +23% | +$134K | 0.1% | 200 |
|
|
2024
Q1 | $510K | Hold |
7,535
| – | – | 0.07% | 227 |
|
|
2023
Q4 | $507K | Sell |
7,535
-1,043
| -12% | -$70.2K | 0.08% | 223 |
|
|
2023
Q3 | $581K | Sell |
8,578
-34
| -0.4% | -$2.3K | 0.09% | 208 |
|
|
2023
Q2 | $616K | Sell |
8,612
-84
| -1% | -$6.01K | 0.09% | 209 |
|
|
2023
Q1 | $604K | Buy |
+8,696
| New | +$604K | 0.09% | 205 |
|